What is the diagnostic approach for trimethylaminuria in a 9-year-old girl with foul-smelling urine after ruling out urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Approach for Trimethylaminuria

Diagnose trimethylaminuria by measuring urinary trimethylamine (TMA) and trimethylamine N-oxide (TMAO) levels, ideally after a marine fish meal challenge, followed by FMO3 gene sequencing for confirmation.

Initial Clinical Assessment

In a 9-year-old girl with foul-smelling urine after excluding UTI, suspect trimethylaminuria when there is a characteristic fishy odor affecting urine, breath, sweat, or other body fluids. The odor typically becomes apparent when dietary sources high in choline or TMAO (particularly marine fish) are introduced 1.

Diagnostic Testing Algorithm

Step 1: Urinary TMA/TMAO Measurement

  • Collect a random urine sample and measure both TMA and TMAO concentrations
  • Calculate the TMA/TMAO ratio - an elevated ratio under basal conditions suggests impaired FMO3 enzyme function 1
  • Normal values: The diagnosis is confirmed when there are elevated urinary TMA levels with an increased TMA/TMAO ratio 2

Step 2: Provocative Testing (if basal testing is equivocal)

Marine fish meal challenge is the preferred method in children 1:

  • Administer a meal containing marine (saltwater) fish
  • Collect urine samples at baseline and post-challenge
  • Advantages: Simple, acceptable to children, effects clear more quickly than choline loading
  • This provides a more physiologic assessment than synthetic choline loading

Alternative: Choline bitartrate loading 1:

  • Useful for estimating residual oxidative capacity
  • Helpful adjunct to molecular studies
  • Effects take longer to clear than fish meal challenge

Step 3: Genetic Confirmation

FMO3 gene sequencing 1, 3:

  • Direct sequencing identifies mutations causing enzyme deficiency
  • Common mutations include P153L (virtually complete loss of function), M82T (some residual capacity), and various compound heterozygous mutations
  • Important caveat: Identical genotypes may present differently - some children with heterozygous mutations show transient childhood trimethylaminuria that may resolve 3

Laboratory Methods

Analytical techniques for urinary measurement include:

  • Nuclear magnetic resonance (NMR) spectroscopy - validated with good accuracy and precision (linearity 2.5-100 mg/L for TMA, 10-1000 mg/L for TMAO) 2
  • MALDI-TOF mass spectrometry - rapid, specific, with CV <3% 4

Key Diagnostic Pitfalls

  • Do not rely solely on clinical presentation - genetic testing and biochemical confirmation are essential 1, 5
  • Transient childhood forms exist - a child may have symptoms despite the same genotype as asymptomatic family members, suggesting age-related FMO3 expression 3
  • Basal testing may be negative - some patients only show abnormalities after dietary challenge 1
  • Heterozygous carriers can occasionally manifest symptoms, particularly in childhood 3

Clinical Correlation

Once diagnosed biochemically and genetically, refer to both a geneticist and dietician for dietary modification focused on reducing choline-rich foods and marine fish intake 5. This significantly improves quality of life in affected children.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.